Results 11 to 20 of about 10,953,879 (308)

12-0-Tetradecanoyl phorbol-13-acetate induced differentiation in human lung squamous carcinoma cells. [PDF]

, 1992
Three human lung squamous carcinoma cell lines (NX002, CX140 and CX143) demonstrate features of squamous differentiation including involucrin synthesis and competence to form cornified envelopes.
?, ?
core   +1 more source

The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970-2004. [PDF]

, 2009
BACKGROUND: Extrapulmonary small cell carcinoma (EPSCC) is a rare cancer and few studies describe its epidemiology. Our objectives were to compare the incidence and survival of EPSCC in South East England with small cell carcinoma of the lung (SCLC), to ...
Jack, Ruth H, Jack Ruth H, Elizabeth A Davies, Jack, Ruth H., Wong Yien, Davies, Elizabeth A.; id_orcid, Henrik Møller, Mak, Vivian, Møller Henrik, Vivian Mak, Wong, Yien Ning S., Mak Vivian, Henrik, Moller; id_orcid, Yien Ning S Wong, Ruth H Jack, Davies Elizabeth A, Henrik, Møller, Davies, Elizabeth A, Wong, Yien Ning S   +18 more
core   +2 more sources

CEA, CYFRA 21-1, NSE, and ProGRP in the diagnosis of lung cancer: a multivariate approach [PDF]

, 2008
We retrospectively studied the single and combined diagnostic value of carcinoembryonic antigen (CEA), cytokeratin fragment 19 (CYFRA 21-1), neuron specific enolase (NSE) and pro-gastrin-releasing peptide (ProGRP), which were routinely analysed in ...
Gruber, Christine, Hatz, Rudolf, Reinmiedl, Judith, Stieber, Petra, Nagel, Dorothea   +4 more
core   +1 more source

Lung Cancer: A Literature Review

Jurnal Respirasi, 2023
Lung cancer is a cancer whose onset starts in the lungs where there is an abnormal cell growth that is very fast and uncontrolled. The abnormal cell growth is triggered by deoxyribonucleic acid (DNA) damage, including deletions in the DNA section ...
Yan Efrata Sembiring, Wiwin Is Effendi, Jeffrey Jeswant Dillon, Heroe Soebroto, Dhihintia Jiwangga Suta Winarno, Puruhito Puruhito, I Gusti Agung Made Adnyanya Putra, Abed Nego Okthara Sebayang, Sri Pramesthi Wisnu Bowo Negoro   +8 more
doaj   +1 more source

Histopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumors [PDF]

Translational Lung Cancer Research, 2016
Lung cancer is the principal cause of cancer-related death worldwide. The use of targeted therapies, especially tyrosine kinase inhibitors (TKIs), in specific groups of patients has dramatically improved the prognosis of this disease, although inevitably some patients will develop resistance to these drugs during active treatment.
Rita, Dorantes-Heredia, José Manuel, Ruiz-Morales, Fernando, Cano-García   +2 more
openaire   +2 more sources

Iris Metastasis in Small-Cell Lung Carcinoma [PDF]

Journal of Thoracic Oncology, 2007
Small-cell lung cancer (SCLC) is characterized by rapid growth and early metastasis. Despite its sensitivity to cytotoxic treatment, until now treatments have failed to control or cure this disease in most patients. Here, we describe a patient with SCLC in which symptoms caused by iris metastasis were the only sign of relapse after multimodality ...
Roenhorst, Anke W. J., van den Bergh, Alphons C. M., van Putten, John W. G., Smit, Egbert F.   +3 more
openaire   +3 more sources

A rare case of pulmonary endobronchial spindle cell carcinoma with liver metastasis along with concurrent cutaneous neurofibroma

The Journal of Association of Chest Physicians, 2023
Spindle cell carcinoma is one of the histological variants of pulmonary sarcomatoid carcinoma. It is a rare, poorly differentiated, highly malignant, and rapidly growing non-small cell carcinoma of the lung.
Pratap Upadhya, C. Sivaselvi, Christie George Joseph, Bheemanathi Hanuman Srinivas   +3 more
doaj   +1 more source

Preoperative CYFRA 21-1 and CEA as Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer [PDF]

, 2008
Objective: To validate the prognostic value of preoperative levels of CYFRA 21-1, CEA and the corresponding tumor marker index (TMI) in patients with stage I non-small cell lung cancer (NSCLC). Methods: Two hundred forty stage I NSCLC patients (80 in pT1
Hatz, Rudolf, Gruber, Christine, Reinmiedl, Judith, Ankerst, Donna Pauler, Seidel, Dietrich, Blankenburg, Florian, Stieber, Petra, Nagel, Dorothea, Blankenburg, F.;Hatz, R.;Nagel, D.;Ankerst, D.;Reinmiedl, J.;Gruber, C.;Seidel, D.;Stieber, P.   +8 more
core   +1 more source

Rare Combined Small Cell Lung Carcinoma and Lung Squamous Cell Carcinoma Response to PD-1 Inhibitor as Third-Line Therapy: A Case Report

Cancer Management and Research, 2023
Zhisheng Liu,1,* Junling Zhang,2,* Yunjie Ge,3 Mengli Huang,2 Ye Wang1 1Department of General Surgery, Affiliated Qingdao Hiser Hospital of Qingdao University (Qingdao Hospital of Traditional Chinese Medicine), Qingdao, Shandong People’s Republic
Liu Z, Zhang J, Ge Y, Huang M, Wang Y
doaj  

Neurotensin in human small cell lung carcinoma [PDF]

British Journal of Cancer, 1984
High levels of neurotensin-like immunoreactivity were found in human small cell lung carcinoma lines. No immunoreactivity was present in non-small cell carcinoma lines and only low amounts in postmortem human lung tissue. The immunoreactive material co-eluted with synthetic neurotensin on two different chromatographic systems.
M, Goedert, J G, Reeve, P C, Emson, N M, Bleehen   +3 more
openaire   +3 more sources